» Articles » PMID: 26853104

Citrus Bergamia Juice Extract Attenuates β-Amyloid-Induced Pro-Inflammatory Activation of THP-1 Cells Through MAPK and AP-1 Pathways

Overview
Journal Sci Rep
Specialty Science
Date 2016 Feb 9
PMID 26853104
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Flavonoids have been shown to be effective in protecting against age-related cognitive and motor decline in both in vitro and in vivo models. Recently, a flavonoid-rich extract of Citrus bergamia juice (BJe) has been shown to display anti-oxidant and anti-inflammatory properties against LPS-induced activation of human THP-1 monocytes. In the light of these observations, we wondered whether BJe may be beneficial against neuroinflammatory processes, such as those observed in Alzheimer's disease. To this aim we used THP-1 monocytes to investigate the mechanisms underlying the beneficial potential of BJe against amyloid-beta1-42 (Aβ1-42) -mediated inflammation. Exposure of THP-1 cells to Aβ1-42 significantly induced the expression and secretion of IL-6 and IL-1β in THP-1 cells and increased the phosphorylation of ERK 1/2 as well as p46 and p54 members of JNK family. Moreover, Aβ1-42 raises AP-1 DNA binding activity in THP-1-treated cells. Interestingly, all these effects were reduced in the presence of BJe. Our data indicate that BJe may effectively counteract the pro-inflammatory activation of monocytes/microglial cells exposed to amyloid fibrils, suggesting a promising role as a natural drug against neuroinflammatory processes.

Citing Articles

Bergamot Byproducts: A Sustainable Source to Counteract Inflammation.

Russo C, Lombardo G, Bruschetta G, Rapisarda A, Maugeri A, Navarra M Nutrients. 2024; 16(2).

PMID: 38257152 PMC: 10819577. DOI: 10.3390/nu16020259.


The Inhibition of Mitogen-Activated Protein Kinases (MAPKs) and NF-κB Underlies the Neuroprotective Capacity of a Cinnamon/Curcumin/Turmeric Spice Blend in Aβ-Exposed THP-1 Cells.

Maugeri A, Russo C, Patane G, Barreca D, Mandalari G, Navarra M Molecules. 2023; 28(24).

PMID: 38138438 PMC: 10745857. DOI: 10.3390/molecules28247949.


Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review).

Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q Int J Mol Med. 2023; 52(5).

PMID: 37800614 PMC: 10558228. DOI: 10.3892/ijmm.2023.5314.


The Anticancer Effect of a Flavonoid-Rich Extract of Bergamot Juice in THP-1 Cells Engages the SIRT2/AKT/p53 Pathway.

Maugeri A, Russo C, Musumeci L, Lombardo G, De Sarro G, Barreca D Pharmaceutics. 2022; 14(10).

PMID: 36297603 PMC: 9610715. DOI: 10.3390/pharmaceutics14102168.


The SIRT2 Pathway Is Involved in the Antiproliferative Effect of Flavanones in Human Leukemia Monocytic THP-1 Cells.

Russo C, Maugeri A, De Luca L, Gitto R, Lombardo G, Musumeci L Biomedicines. 2022; 10(10).

PMID: 36289647 PMC: 9598940. DOI: 10.3390/biomedicines10102383.


References
1.
Giri R, Selvaraj S, Kalra V . Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol. 2003; 170(10):5281-94. DOI: 10.4049/jimmunol.170.10.5281. View

2.
Lioi A, Rodriguez A, Funderburg N, Feng Z, Weinberg A, Sieg S . Membrane damage and repair in primary monocytes exposed to human β-defensin-3. J Leukoc Biol. 2012; 92(5):1083-91. PMC: 4050522. DOI: 10.1189/jlb.0112046. View

3.
Impellizzeri D, Bruschetta G, Di Paola R, Ahmad A, Campolo M, Cuzzocrea S . The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. Clin Nutr. 2014; 34(6):1146-54. DOI: 10.1016/j.clnu.2014.11.012. View

4.
Benavente-Garcia O, Castillo J . Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem. 2008; 56(15):6185-205. DOI: 10.1021/jf8006568. View

5.
Nie Y, Wu H, Li P, Xie L, Luo Y, Shen J . Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways. Eur J Pharmacol. 2012; 690(1-3):207-13. DOI: 10.1016/j.ejphar.2012.06.040. View